Dr. Agarwal’s Health Care Limited announced that ICRA Limited has ‘re-affirmed’ and ‘assigned’ credit ratings for its existing and enhanced debt facilities as of February 23, 2026. The long-term loan facilities totaling ₹73.80 crore have been re-affirmed at ICRA AA- (Stable). Furthermore, unallocated limits of ₹126.20 crore received a re-affirmation and new assignment rating of ICRA AA- (Stable) / ICRA A1+ for the enhanced amount.
Credit Rating Update Announcement
Dr. Agarwal’s Health Care Limited issued an update regarding its credit ratings following a review by ICRA Limited. This disclosure concerns the debt facilities currently utilized by the Company, as confirmed by the letter dated February 23, 2026.
Details of Re-affirmed Long-Term Loan Ratings
The existing long-term loan facilities, provided by HDFC Bank Limited, YES Bank Limited, and ICICI Bank Limited, totaling ₹73.80 crore, have received a rating reaffirmation. The specific rating assigned to this aggregate amount is ICRA AA- (Stable).
| Bank Facility | Bank | Amount (in Crores) | Outstanding Rating | Rating Action |
|---|---|---|---|---|
| Long Term Loan | HDFC Bank Limited | 48.00 | ICRA AA- (Stable) | Re-affirmed |
| YES Bank Limited | 9.00 | |||
| ICICI Bank Limited | 16.80 | |||
| Total | 73.80 |
Ratings for Enhanced Unallocated Limits
In addition to the reaffirmations, the Company’s Long-Term / Short-Term Unallocated limits, which have been enhanced, received a joint rating assignment. The total quantum for these limits stands at ₹126.20 crore. The rating assigned is a dual rating of ICRA AA- (Stable) / ICRA A1+, which represents both a re-affirmation and an assignment for the increased credit exposure.
| Bank Facility | Amount (in Crores) | Outstanding Rating | Rating Action |
|---|---|---|---|
| Long-Term / Short-Term Unallocated limits | 126.20 | ICRA AA- (Stable)/ ICRA A1+ | Re-affirmed and assigned for enhanced amount |
The management of Dr. Agarwal’s Health Care Limited has requested that the stock exchanges take this information on record as per the required disclosure timelines.
Source: BSE
